Heparin has been recognized as a valuable anticoagulant and antithrombotic for several
decades and is still widely used in clinical practice for a variety of indications. The …

The first international guidance on antithrombotic therapy in the elderly came from the
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …

5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

The contribution of natural products (NPs) to cardiovascular medicine has been extensively
documented, and many have been used for centuries. Cardiovascular disease (CVD) is the …

Aims To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the
development of new treatments and ischaemic outcomes over the last 20 years in a …

This review highlights the increased risk of cardiovascular disease and the dismal prognosis
after acute coronary events when diabetes is present. Although there have been …

Background This meta-epidemiological study aimed to assess methodological quality of a
sample of contemporary non-randomised clinical studies of clinical interventions. Methods …

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting
without persistent ST-segment elevatio Page 1 ESC GUIDELINES 2015 ESC Guidelines for the …

Anticoagulation in conjunction with antiplatelet therapy is central to the management of
acute coronary syndromes (ACS). When used effectively it is associated with a reduction in …

With the aim to expand the randomized controlled trial evidence of cinacalcet treatment to
the unselected, general chronic kidney disease (CKD) population we analysed a large …